Cosomil ^None

Cosomil is a company focused on developing early diagnostic drugs for diseases using their single enzyme activity-based liquid biopsy technology. They also provide research and development support to healthcare companies. The company is dedicated to advancing early cancer detection through blood-based methods. There is no information provided about investors, valuation, or other details of the company profile.